Healthcare well placed to deliver third year of outperformance

In a world where uncertainties abound, growth is slowing, confidence is weak, and increased volatility likely the norm, we believe healthcare is well-placed to follow its two year outperformance and pull off a hat-trick. However, multiple expansion has lifted valuations, making selectively key and us looking for opportunistic entry-points on pull-backs. Nevertheless, disparate valuations and business models across four key verticals (eg pharmaceuticals; services; medical devices; diagnostics) offer broad exposure and portfolio diversification, while AUD weakness represents a tailwind for offshore earnings. We resume coverage on ANN, COH, CSL, HSO, PRY, RHC, RMC, and SHL. Research here: (VIEW LINK)


2 topics

Senior Analyst

Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...


No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.